Dietrich Häfner

1.3k total citations
21 papers, 991 citations indexed

About

Dietrich Häfner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Dietrich Häfner has authored 21 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Dietrich Häfner's work include Neonatal Respiratory Health Research (14 papers), Respiratory Support and Mechanisms (13 papers) and Asthma and respiratory diseases (7 papers). Dietrich Häfner is often cited by papers focused on Neonatal Respiratory Health Research (14 papers), Respiratory Support and Mechanisms (13 papers) and Asthma and respiratory diseases (7 papers). Dietrich Häfner collaborates with scholars based in Germany, United States and United Kingdom. Dietrich Häfner's co-authors include Paul‐Georg Germann, Roger G. Spragg, James F. Lewis, Dieter Hauschke, Werner Seeger, Gerd Rippin, Friedemann Taut, Andreas Nandy, Machiko Ikegami and Alan H. Jobe and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Dietrich Häfner

20 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dietrich Häfner Germany 13 815 251 136 126 118 21 991
Chiara Autilio Spain 15 514 0.6× 94 0.4× 101 0.7× 14 0.1× 52 0.4× 39 759
Emilio García-Prieto Spain 13 346 0.4× 34 0.1× 45 0.3× 61 0.5× 100 0.8× 25 559
J. F. Lewis Canada 14 1.1k 1.3× 435 1.7× 47 0.3× 150 1.2× 103 0.9× 17 1.2k
Hans‐Dieter Walmrath Germany 8 529 0.6× 91 0.4× 29 0.2× 81 0.6× 203 1.7× 13 870
Peter A. Sloane United States 11 522 0.6× 27 0.1× 146 1.1× 23 0.2× 65 0.6× 13 775
M S Kavuru United States 13 572 0.7× 21 0.1× 430 3.2× 29 0.2× 254 2.2× 24 962
Cynthia R. Reed United States 10 470 0.6× 179 0.7× 20 0.1× 50 0.4× 66 0.6× 19 794
Gerald W. Staton United States 16 327 0.4× 17 0.1× 172 1.3× 28 0.2× 234 2.0× 28 718
Cosimo Tortorella Italy 9 187 0.2× 13 0.1× 31 0.2× 79 0.6× 76 0.6× 13 373
G S Basran United Kingdom 17 252 0.3× 7 0.0× 173 1.3× 52 0.4× 89 0.8× 29 649

Countries citing papers authored by Dietrich Häfner

Since Specialization
Citations

This map shows the geographic impact of Dietrich Häfner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dietrich Häfner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dietrich Häfner more than expected).

Fields of papers citing papers by Dietrich Häfner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dietrich Häfner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dietrich Häfner. The network helps show where Dietrich Häfner may publish in the future.

Co-authorship network of co-authors of Dietrich Häfner

This figure shows the co-authorship network connecting the top 25 collaborators of Dietrich Häfner. A scholar is included among the top collaborators of Dietrich Häfner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dietrich Häfner. Dietrich Häfner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nandy, Andreas, et al.. (2015). Recombinant allergens in specific immunotherapy. Allergo Journal International. 24(5). 143–151. 8 indexed citations
2.
Häfner, Dietrich, Kristian Reich, I. Zschocke, et al.. (2012). Prospective validation of the “rhino conjunctivitis allergy‐control‐SCORE©” (RC‐ACS©). Clinical and Translational Allergy. 2(1). 17–17. 6 indexed citations
3.
Cromwell, Oliver, Dietrich Häfner, & Andreas Nandy. (2011). Recombinant allergens for specific immunotherapy. Journal of Allergy and Clinical Immunology. 127(4). 865–872. 71 indexed citations
4.
Taut, Friedemann, Gerd Rippin, Peter Schenk, et al.. (2008). A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy. CHEST Journal. 134(4). 724–732. 68 indexed citations
5.
Häfner, Dietrich, et al.. (2008). The Impact of Incorporating Clinical Relevance on the Feasibility of Clinical Trials. Drug Information Journal. 42(2). 99–106. 4 indexed citations
6.
Stoeck, Michael, R. M. Riedel, Günther Hochhaus, et al.. (2004). In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide. Journal of Pharmacology and Experimental Therapeutics. 309(1). 249–258. 87 indexed citations
7.
Spragg, Roger G., James F. Lewis, Hans‐Dieter Walmrath, et al.. (2004). Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome. New England Journal of Medicine. 351(9). 884–892. 273 indexed citations
8.
Spragg, Roger G., James F. Lewis, W Wurst, et al.. (2003). Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant. American Journal of Respiratory and Critical Care Medicine. 167(11). 1562–1566. 127 indexed citations
9.
Häfner, Dietrich, Mohammad A. A. Ibrahim, Lutz Wollin, & Paul‐Georg Germann. (2003). Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of Acute Respiratory Distress Syndrome (ARDS). Experimental and Toxicologic Pathology. 55(1). 59–68. 4 indexed citations
10.
Vangerow, Burkhard, et al.. (2001). Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury. Intensive Care Medicine. 27(9). 1526–1531. 7 indexed citations
11.
Häfner, Dietrich & Paul‐Georg Germann. (2000). Additive Effects of Phosphodiesterase-4 Inhibition on Effects of rSP-C Surfactant. American Journal of Respiratory and Critical Care Medicine. 161(5). 1495–1500. 20 indexed citations
12.
McCaig, Lynda, et al.. (1999). Dosing and Delivery of a Recombinant Surfactant in Lung-injured Adult Sheep. American Journal of Respiratory and Critical Care Medicine. 159(3). 741–747. 34 indexed citations
13.
Häfner, Dietrich & Paul‐Georg Germann. (1999). Dexamethasone enhances the activity of rSP-C surfactant but not of Exosurf in a rat model of the acute lung injury. Journal of Pharmacological and Toxicological Methods. 42(1). 39–48. 8 indexed citations
14.
Häfner, Dietrich & Paul‐Georg Germann. (1999). A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant. Journal of Pharmacological and Toxicological Methods. 41(2-3). 97–106. 13 indexed citations
15.
Germann, Paul‐Georg, et al.. (1999). Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity. Experimental and Toxicologic Pathology. 51(6). 495–505. 6 indexed citations
16.
Jobe, Alan H., et al.. (1998). Lung Function in Premature Lambs and Rabbits Treated with a Recombinant SP-C Surfactant. American Journal of Respiratory and Critical Care Medicine. 157(2). 553–559. 101 indexed citations
17.
Häfner, Dietrich, Paul‐Georg Germann, & Dieter Hauschke. (1998). Effects of rSP-C Surfactant on Oxygenation and Histology in a Rat-Lung-Lavage Model of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 158(1). 270–278. 54 indexed citations
18.
Germann, Paul‐Georg & Dietrich Häfner. (1998). A rat model of acute respiratory distress syndrome (ARDS): part 1. time dependency of histological and pathological changes. Journal of Pharmacological and Toxicological Methods. 40(2). 101–107. 25 indexed citations
19.
Häfner, Dietrich, Paul‐Georg Germann, & Dieter Hauschke. (1998). Comparison of rSP‐C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. British Journal of Pharmacology. 124(6). 1083–1090. 32 indexed citations
20.
Häfner, Dietrich, et al.. (1995). Dose‐response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS). British Journal of Pharmacology. 115(3). 451–458. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Autilio Breakdown of academic impact, for papers by Emilio García-Prieto Breakdown of academic impact, for papers by J. F. Lewis Breakdown of academic impact, for papers by Hans‐Dieter Walmrath Breakdown of academic impact, for papers by Peter A. Sloane Breakdown of academic impact, for papers by M S Kavuru Breakdown of academic impact, for papers by Cynthia R. Reed Breakdown of academic impact, for papers by Gerald W. Staton Breakdown of academic impact, for papers by Cosimo Tortorella Breakdown of academic impact, for papers by G S Basran
Rankless by CCL
2026